Home > Insider Trading > Filing (0001104659-18-042299)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1674365	Aptinyx Inc.	APTX	Pharmaceutical Preparations (2834)	474626057

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1741305	Andrew Kidd	C/O Aptinyx Inc. 909 Davis Street, Suite 600 Evanston IL 60201	Chief Commercial Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2018-06-25	2,433	$0.00	2,433	No	4	C	Direct
Common Stock	Acquisiton	2018-06-25	6,700	$16.00	9,133	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	C	Direct
No	4	P	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Series B Convertible Preferred Stock	Disposition	2018-06-25	67,130	$0.00	2,433	$0.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0			No	4	C	Direct

Footnotes

Each share of Series B Convertible Preferred Stock automatically converted into shares of Common Stock on a 27.58621-for-one basis immediately prior to the closing of the Issuer's initial public offering without payment or consideration. The shares of Series B Convertible Preferred Stock had no expiration date.
On June 25, 2018, the Reporting Person purchased 6,700 shares of common stock of the Issuer at a price of $16.00 per share pursuant to an underwritten public offering.